Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02633969 · ClinicalTrials.gov registry record · Phase 2
Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age
A Phase 2 study, sponsored by Iroko Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT02633969 is a Phase 2 study that has completed, run by Iroko Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT02633969, a Phase 2 study, has completed, sponsored by Iroko Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purposes of this study are to evaluate the safety and tolerability and to model the single-dose pharmacokinetic profile of indomethacin capsules low dose and high dose in children ages 6 to \<17 years experiencing mild to moderate acute postoperative pain.
Interventions
- DRUG Indomethacin Capsules low dose
- DRUG Indomethacin Capsules high dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02633969
The ClinicalTrials.gov registry entry for NCT02633969 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iroko Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indomethacin Capsules low dose is the first listed.
NCT02633969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02633969 about?
NCT02633969 is a clinical study titled "Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age". The purposes of this study are to evaluate the safety and tolerability and to model the single-dose pharmacokinetic profile of indomethacin capsules low dose and high dose in children ages 6 to \<17 years experiencing mild to moderate acute postoperative pain.
What is the current status of trial NCT02633969?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2015-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02633969?
The interventions under investigation include: Indomethacin Capsules low dose (DRUG), Indomethacin Capsules high dose (DRUG).
Who is sponsoring clinical trial NCT02633969?
This trial is sponsored by Iroko Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.